PMC4532892_01
PMC4532892_02
PMC4532892_03
(a) PET CT before treatment. Arrow shows metabolically active area referring to vulvar lesion. (b) CT correlation. (c) PET CT after treatment.
CRIOG2015-139817.002.jpg
PMC4532892_05_CRIOG2015-139817.002.jpg
fig2
She is currently being followed by our service on a regular basis and is without evidence of disease recurrence over 4 years after primary treatment (see Figure 2).
PMC4532892_04
EGFR immunostain with cytoplasmic staining. The brown staining shows where the EGFR is detected.
CRIOG2015-139817.001.jpg
PMC4532892_04_CRIOG2015-139817.001.jpg
fig1
Our patient was determined to have FIGO stage IIIB squamous cell carcinoma of the vulva (see Figure 1). Given our concern for the high risk of recurrence, the patient's primary tumor was tested and noted to be epidermal growth factor receptor (EGFR) positive (see Figure 1).
PMC4532892_05
(a) PET CT before treatment. Arrow shows metabolically active area referring to vulvar lesion. (b) CT correlation. (c) PET CT after treatment.
CRIOG2015-139817.002.jpg
PMC4532892_05_CRIOG2015-139817.002.jpg
fig2
She is currently being followed by our service on a regular basis and is without evidence of disease recurrence over 4 years after primary treatment (see Figure 2).